Role of α-1 Anti Trypsin, A Constitutive Form of Nitric Oxide Synthase in Cyclic AMP Mediated Inhibition of Platelet Aggregation
Journal Title: Haematology International Journal - Year 2017, Vol 1, Issue 1
Abstract
1.1. Introduction: As reported before, the treatment of platelets with all currently known platelet aggregating agents was resulted in the reduction of nitric oxide (NO) synthesis through the inhibition of enzyme nitric oxide synthase (NOS). This reduction of NO in consequence released arachidonic acid from the platelet membrane ultimately leading to the aggregation of platelets. 1.2. Aim: Experiments were carried out to identify the platelet NOS. 1.3. Results: The amino acid sequence of the protein sample thus prepared was determined by mass spectrometry in which the platelet cytosolic NOS was identified to be α1 anti trypsin (AAT) when matched with the protein databank. The incubation of NOS/AAT with l-arginine resulted in the increase of NO synthesis to ~1nmol/h (P<0.01) compared to control measured by methemoglobin method. Similarly, addition of 80µM aspirin to NOS/AAT also stimulated the NO synthesis activity of the protein. In contrast, the treatment of the purified protein with platelet aggregating agents including 4µM ADP, 2µg/ml collagen, 5µM thrombin, 5µM epinephrine, 0.1µM dermcidin and 0.1mM l-NAME inhibited NOS activity of AAT. Additionally, the incubation of NOS with cAMP resulted in the binding of cAMP to the purified protein. Scatchard plot analysis of the binding of cAMP to AAT demonstrated Kd =15.54nM with 1.56 X 103 molecules of cAMP bound to each AAT molecule. It was found that the binding of cAMP to AAT resulted in the lack of inhibition of the NOS activity of AAT by the aggregating agents. Conclusion: The identification of the NOS as the AAT can be a therapeutic target for the treatment of acute coronary syndromes.
Authors and Affiliations
Debipriya Banerjee
Keywords
Related Articles
- EP ID EP291034
- DOI -
- Views 93
- Downloads 0
Multiple Myeloma in Cameroon: Clinico-Biological Characteristics of Patients; an Experience from Douala General Hospital
1.1. Background: Multiple myeloma is the most common haematological malignancy among blacks. There is paucity of data on this subject in Africa in general and Cameroon in Cameroon. This study aims at describing initial c...
What Clinicians Should Know About the Use of Albumin
The advantages of albumin over less costly alternative fluids continue to be debated. Many scientific articles were devoted to the clinical analysis of the use of albumin in acute illness as well as its comparison with o...
Expanding the Classification of Leukemia by the World Health Organization over Time
The classification has always been the basis for many treatments of the disease. The French-American-British has performed leukemia classification base on morphological finding, but the World Health Organization apply ge...
The Stellar, Astral Reproduction: Burkitt ‘S Lymphoma
An infrequent (≤1.2%), aggressive B lymphocyte non hodgkin’s lymphoma is designated as a Burkitt’s lymphoma, which may present as an extra-nodal tumefaction or as an acute leukaemia [1]. A well delineated clinico-patholo...
A Unique Case of Primary Hepatic CD30-Positive, CD15-Negative Classical Hodgkin’s Lymphoma Presenting as Fever of Unknown Origin and Acute Hepatic Failure
Hodgkin’s lymphoma is a B-cell lymphoproliferative neoplasm that commonly presents with lymphadenopathy and constitutional symptoms. Primary Hodgkin’s lymphoma of the liver without extrahepatic lymphadenopathy is rare, r...